All < Article List

Homegrown blood cancer drug PHI-101 wins ODD in Europe following US
Bio Kim Kyoung-Won 06.25 14:42
AbbVie’s Rinvoq expands reimbursement in Korea for psoriatic arthritis
Pharma Lee Han-soo 06.25 14:39
SNUH successfully operates on difficult ovarian cancer with the Hugo robot
Hospital Kim Kyoung-Won 06.25 14:25
[Interview] HIV nears a cure -- but stigma still holds us back
Pharma Kim Yun-mi 06.25 13:56
Why does Korea's bio approval system still rely on temporary task force?
Policy Kwak Sung-sun 06.25 11:48
ABION BIO signs $1.3 billion antibody drug licensing deal for CLDN3-targeted cancer therapy
Bio Lee Han-soo 06.25 11:15
ABL Bio announces global leap with 'Vision 2.0' in new Gangnam headquarters
Bio Hong Sook 06.25 10:56
Self-employed Koreans more likely to die after heart attack, study finds
Hospital Korea Biomedical Review 06.25 10:38
AZ redefines endometrial and ovarian cancer playbook
Pharma Lee Han-soo 06.25 09:05
After 9-year wait, Boehringer’s IPF drug Ofev faces generic threat weeks into Korea launch
Pharma Kim Ji-hye 06.24 18:29
Siemens Healthineers Korea, Phantomics sign MOU to expand AI-powered cardiac MRI accessibility
Device/ICT Lee Han-soo 06.24 16:52
Vaxcellbio wins grant for CAR-MIL as BMS, J&J face Korea roadblocks
Bio Kim Ji-hye 06.24 16:15
Cracks emerge in trainee doctors’ strike as hospital chapters urge negotiated return
Hospital Song Soo-youn 06.24 15:34
Gilead’s Vemlidy secures expanded pediatric approval for chronic hepatitis B in Korea
Pharma Lee Han-soo 06.24 15:17
[Column] Is it safe to take medication and drive?
Opinion Jeong Jae-hoon 06.24 15:11
Inventage Lab unveils next-generation obesity treatment at ADA meeting
Bio Hong Sook 06.24 15:06
ABL Bio’s partner to unveil ABL111 combo therapy’s phase 1 results in Europe
Bio Hong Sook 06.24 14:50
Debate heats up over Lee’s campaign pledge to establish a public medical school
Policy Kim Jung-hyun 06.24 14:33
Severance Hospital surpasses 3,000 hearing implant surgeries
Hospital Lee Han-soo 06.24 13:46
[Column] Rare but deadly parathyroid cancer and atypical parathyroid tumor
Opinion Park Hye-sun 06.24 13:21

상단영역

본문영역

All articles 목록 ( 총 : 21,030 )

기사목록 보기 형태

Homegrown blood cancer drug PHI-101 wins ODD in Europe following US

AbbVie’s Rinvoq expands reimbursement in Korea for psoriatic arthritis

SNUH successfully operates on difficult ovarian cancer with the Hugo robot

[Interview] HIV nears a cure -- but stigma still holds us back

Why does Korea's bio approval system still rely on temporary task force?

ABION BIO signs $1.3 billion antibody drug licensing deal for CLDN3-targeted cancer therapy

ABL Bio announces global leap with 'Vision 2.0' in new Gangnam headquarters

Self-employed Koreans more likely to die after heart attack, study finds

AZ redefines endometrial and ovarian cancer playbook

After 9-year wait, Boehringer’s IPF drug Ofev faces generic threat weeks into Korea launch

Siemens Healthineers Korea, Phantomics sign MOU to expand AI-powered cardiac MRI accessibility

Vaxcellbio wins grant for CAR-MIL as BMS, J&J face Korea roadblocks

Cracks emerge in trainee doctors’ strike as hospital chapters urge negotiated return

Gilead’s Vemlidy secures expanded pediatric approval for chronic hepatitis B in Korea

[Column] Is it safe to take medication and drive?

Inventage Lab unveils next-generation obesity treatment at ADA meeting

ABL Bio’s partner to unveil ABL111 combo therapy’s phase 1 results in Europe

Debate heats up over Lee’s campaign pledge to establish a public medical school

Severance Hospital surpasses 3,000 hearing implant surgeries

[Column] Rare but deadly parathyroid cancer and atypical parathyroid tumor